Increased vascular permeability is a key feature of the pathological symptoms caused by hantaviruses. Here, we analysed the interaction between hantaviruses and mast cells, which regulate vascular homeostasis. In highly purified human skin mast cells increasing amounts of Hantaan (HTNV) and, to a lower extent, Prospect Hill (PHV) virions were produced. Replication was confirmed by the production of viral plus-strand RNA as determined by a virus strand-specific RT-PCR. PHV but not HTNV elicited early expression of beta interferon, MxA, ISG15 and CCL5 consistent to studies with other cell types. The data demonstrate that mature mast cells are permissive to infection with hantaviruses. This interaction might contribute to the development of vascular leakage syndrome.


Article metrics loading...

Loading full text...

Full text loading...



  1. Alff, P. J., Gavrilovskaya, I. N., Gorbunova, E., Endriss, K., Chong, Y., Geimonen, E., Sen, N., Reich, N. C. & Mackow, E. R.(2006). The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80, 9676–9686.[CrossRef] [Google Scholar]
  2. Babina, M., Guhl, S., Starke, A., Kirchhof, L., Zuberbier, T. & Henz, B. M.(2004). Comparative cytokine profile of human skin mast cells from two compartments – strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming. J Leukoc Biol 75, 244–252. [Google Scholar]
  3. Bannert, N., Farzan, M., Friend, D. S., Ochi, H., Price, K. S., Sodroski, J. & Boyce, J. A.(2001). Human mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro. J Virol 75, 10808–10814.[CrossRef] [Google Scholar]
  4. Brown, M. G., King, C. A., Sherren, C., Marshall, J. S. & Anderson, R.(2006). A dominant role for FcγRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol 80, 1242–1250.[CrossRef] [Google Scholar]
  5. Galli, S. J., Nakae, S. & Tsai, M.(2005). Mast cells in the development of adaptive immune responses. Nat Immunol 6, 135–142.[CrossRef] [Google Scholar]
  6. Gavrilovskaya, I. N., Shepley, M., Shaw, R., Ginsberg, M. H. & Mackow, E. R.(1998).β3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A 95, 7074–7079.[CrossRef] [Google Scholar]
  7. Gavrilovskaya, I. N., Peresleni, T., Geimonen, E. & Mackow, E. R.(2002). Pathogenic hantaviruses selectively inhibit β3 integrin directed endothelial cell migration. Arch Virol 147, 1913–1931.[CrossRef] [Google Scholar]
  8. Gavrilovskaya, I. N., Gorbunova, E. E., Mackow, N. A. & Mackow, E. R.(2008). Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol 82, 5797–5806.[CrossRef] [Google Scholar]
  9. Geimonen, E., Neff, S., Raymond, T., Kocer, S. S., Gavrilovskaya, I. N. & Mackow, E. R.(2002). Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A 99, 13837–13842.[CrossRef] [Google Scholar]
  10. Handke, W., Oelschlegel, R., Franke, R., Krüger, D. H. & Rang, A.(2009). Hantaan virus triggers TLR3-dependent innate immune responses. J Immunol 182, 2849–2858.[CrossRef] [Google Scholar]
  11. Heib, V., Becker, M., Taube, C. & Stassen, M.(2008). Advances in the understanding of mast cell function. Br J Haematol 142, 683–694.[CrossRef] [Google Scholar]
  12. Khaiboullina, S. F., Morzunov, S. P. & St Jeor, S. C.(2005). Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med 5, 773–790.[CrossRef] [Google Scholar]
  13. King, C. A., Marshall, J. S., Alshurafa, H. & Anderson, R.(2000). Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol 74, 7146–7150.[CrossRef] [Google Scholar]
  14. King, C. A., Anderson, R. & Marshall, J. S.(2002). Dengue virus selectively induces human mast cell chemokine production. J Virol 76, 8408–8419.[CrossRef] [Google Scholar]
  15. Kirshenbaum, A. S., Goff, J. P., Semere, T., Foster, B., Scott, L. M. & Metcalfe, D. D.(1999). Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-kit+, and expresses aminopeptidase N (CD13). Blood 94, 2333–2342. [Google Scholar]
  16. Kneilling, M. & Rocken, M.(2009). Mast cells: novel clinical perspectives from recent insights. Exp Dermatol 18, 488–496.[CrossRef] [Google Scholar]
  17. Kraus, A. A., Raftery, M. J., Giese, T., Ulrich, R., Zawatzky, R., Hippenstiel, S., Suttorp, N., Krüger, D. H. & Schönrich, G.(2004). Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J Virol 78, 6143–6150.[CrossRef] [Google Scholar]
  18. Kuchler, J., Grutzkau, A., Henz, B. M. & Kruger-Krasagakis, S.(2006). Morphological analysis of integrin-mediated adhesion of immature human mast cells to extracellular matrix proteins. Arch Dermatol Res 298, 153–161.[CrossRef] [Google Scholar]
  19. Kulka, M. & Metcalfe, D. D.(2006). TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol Immunol 43, 1579–1586.[CrossRef] [Google Scholar]
  20. Linderholm, M., Ahlm, C., Settergren, B., Waage, A. & Tarnvik, A.(1996). Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 173, 38–43.[CrossRef] [Google Scholar]
  21. Marshall, J. S.(2004). Mast-cell responses to pathogens. Nat Rev Immunol 4, 787–799.[CrossRef] [Google Scholar]
  22. Mekori, Y. A. & Metcalfe, D. D.(2000). Mast cells in innate immunity. Immunol Rev 173, 131–140.[CrossRef] [Google Scholar]
  23. Okumura, S., Kashiwakura, J., Tomita, H., Matsumoto, K., Nakajima, T., Saito, H. & Okayama, Y.(2003). Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcϵRI. Blood 102, 2547–2554.[CrossRef] [Google Scholar]
  24. Peters, C. J., Simpson, G. L. & Levy, H.(1999). Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med 50, 531–545.[CrossRef] [Google Scholar]
  25. Raftery, M. J., Kraus, A. A., Ulrich, R., Krüger, D. H. & Schönrich, G.(2002). Hantavirus infection of dentritic cells. J Virol 76, 10724–10733.[CrossRef] [Google Scholar]
  26. Rang, A., Heider, H., Ulrich, R. & Krüger, D. H.(2006). A novel method for cloning of non-cytolytic viruses. J Virol Methods 135, 26–31.[CrossRef] [Google Scholar]
  27. Schmaljohn, C. & Hjelle, B.(1997). Hantaviruses: a global disease problem. Emerg Infect Dis 3, 95–104.[CrossRef] [Google Scholar]
  28. Schönrich, G., Rang, A., Lutteke, N., Raftery, M. J., Charbonnel, N. & Ulrich, R. G.(2008). Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev 225, 163–189.[CrossRef] [Google Scholar]
  29. Sidelnikov, L. N. & Sivoraksha, G. A.(1990). The participation of histamine and serotonin in the genesis of acute kidney failure in patients with hemorrhagic fever with renal syndrome. Urol Nefrol (Mosk) 4, 46–48. in Russian [Google Scholar]
  30. Sidelnikov, L. N. & Sivoraksha, G. A.(1996). The histamine and serotonin content in the kidneys of patients with hemorrhagic fever with renal syndrome. Urol Nefrol (Mosk) 4, 19–21. in Russian [Google Scholar]
  31. Spiropoulou, C. F., Albarino, C. G., Ksiazek, T. G. & Rollin, P. E.(2007). Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 81, 2769–2776.[CrossRef] [Google Scholar]
  32. Sundstrom, J. B., McMullan, L. K., Spiropoulou, C. F., Hooper, W. C., Ansari, A. A., Peters, C. J. & Rollin, P. E.(2001). Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol 75, 6070–6085.[CrossRef] [Google Scholar]
  33. Sundstrom, J. B., Ellis, J. E., Hair, G. A., Kirshenbaum, A. S., Metcalfe, D. D., Yi, H., Cardona, A. C., Lindsay, M. K. & Ansari, A. A.(2007). Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood 109, 5293–5300.[CrossRef] [Google Scholar]
  34. Sundstrom, J. B., Hair, G. A., Ansari, A. A., Secor, W. E., Gilfillan, A. M., Metcalfe, D. D. & Kirshenbaum, A. S.(2009). IgE–FcϵRI interactions determine HIV coreceptor usage and susceptibility to infection during ontogeny of mast cells. J Immunol 182, 6401–6409.[CrossRef] [Google Scholar]
  35. Tan, G. K. & Alonso, S.(2009). Pathogenesis and prevention of dengue virus infection: state-of-the-art. Curr Opin Infect Dis 22, 302–308.[CrossRef] [Google Scholar]
  36. Temonen, M., Mustonen, J., Helin, H., Pasternack, A., Vaheri, A. & Holthofer, H.(1996). Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 78, 47–55.[CrossRef] [Google Scholar]
  37. Varadaradjalou, S., Feger, F., Thieblemont, N., Hamouda, N. B., Pleau, J. M., Dy, M. & Arock, M.(2003). Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 33, 899–906.[CrossRef] [Google Scholar]
  38. Welker, P., Grabbe, J., Zuberbier, T., Guhl, S. & Henz, B. M.(2000). Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. J Invest Dermatol 114, 44–50.[CrossRef] [Google Scholar]
  39. Zaki, S. R., Khan, A. S., Goodman, R. A., Armstrong, L. R., Greer, P. W., Coffield, L. M., Ksiazek, T. G., Rollin, P. E., Peters, C. J. & Khabbaz, R. F.(1996). Retrospective diagnosis of hantavirus pulmonary syndrome, 1978–1993: implications for emerging infectious diseases. Arch Pathol Lab Med 120, 134–139. [Google Scholar]

Data & Media loading...


vol. , part 5, pp. 1256 - 1261

RT-PCR primers used to detect viral plus- and minus-strand RNA

Primers used for standard RT-PCR [Single PDF file](49 KB)


Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error